How much does Entresto lower blood pressure in clinical studies?
Entresto (sacubitril/valsartan) lowers blood pressure, but the size of the drop depends on the dose and what baseline blood pressure patients have. In the major trials that evaluated cardiovascular outcomes, Entresto produced a modest average reduction in systolic blood pressure (the top number).
Because your question asks “how much,” the most useful way to answer is by the average change reported in studies rather than an exact single number for all patients. The magnitude typically falls in the “several mmHg” range for systolic blood pressure, alongside similar modest effects on diastolic blood pressure.
What’s the expected change for systolic vs diastolic pressure?
In practice, patients and clinicians usually track systolic blood pressure first. Entresto’s blood-pressure effect is generally described as a modest lowering of systolic pressure and a smaller decrease in diastolic pressure than the systolic change.
If you want, tell me the dose you’re asking about (e.g., 24/26 mg, 49/51 mg, 97/103 mg twice daily) and whether the patient is starting from normal BP or is already on low BP—then the estimate can be more targeted.
How fast does Entresto lower blood pressure?
Blood pressure effects from ARNI therapy are typically seen early after starting or increasing the dose, since it contains an angiotensin receptor blocker (valsartan). The full effect is often assessed over days to weeks, with monitoring used to guide dose adjustments.
What if a patient already has low blood pressure?
Entresto can cause hypotension, especially in people with lower baseline blood pressure, dehydration, or those taking other blood-pressure-lowering medicines. Clinicians may reduce the dose, adjust other medications, or slow the titration if blood pressure drops too far.
Sources
I don’t have the specific Entresto blood-pressure reduction numbers you’re asking for in the information provided here. If you share the trial label excerpt or prescribing information you’re using (or the dose and patient setting), I can compute/translate it into a clear mmHg expectation.
If you want a specific numeric estimate from a regulator-facing document, point me to the label version (FDA label year or the PDF/URL) and I’ll extract the exact systolic/diastolic changes.